Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT00877383

Public ClinicalTrials.gov record NCT00877383. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Controlled, Parallel-group, 12-week Study to Compare the Efficacy and Safety of the Combination of Indacaterol 150 µg Once Daily With Open Label Tiotropium 18 µg Once Daily Versus Open Label Tiotropium 18 µg Once Daily in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in patients with chronic obstructive pulmonary disease (COPD).

Study identification

NCT ID
NCT00877383
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,142 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
Feb 2010 (Actual)
Completion
Feb 2010 (Actual)
Last update posted
Aug 25, 2011

2009 – 2010

United States locations

U.S. sites
116
U.S. states
35
U.S. cities
105
Facility City State ZIP Site status
Novartis Investigator Site Anniston Alabama 36207-5710 —
Novartis Investigator Site Birmingham Alabama 35249-2181 —
Novartis Investigator Site Jasper Alabama 35501 —
Novartis Investigator Site Mobile Alabama 36608-1128 —
Novartis Investigator Site Glendale Arizona 85306 —
Novartis Investigator Site Phoenix Arizona 85006 —
Novartis Investigator Site Phoenix Arizona 85013 —
Novartis Investigator Site Scottsdale Arizona 85251 —
Novartis Investigator Site Little Rock Arkansas 72205 —
Novartis Investigator Site Buena Park California 90620 —
Novartis Investigator Site Fullerton California 92835 —
Novartis Investigator Site Mission Viejo California 92691 —
Novartis Investigator Site San Ramon California 94583 —
Novartis Investigator Site Santa Barbara California 93110 —
Novartis Investigator Site Sepulveda California 91343 —
Novartis Investigator Site Spring Valley California 91978 —
Novartis Investigator Site Torrance California 90502 —
Novartis Investigator Site Torrance California 90505 —
Novartis Investigator Site Vista California 92083 —
Novartis Investigator Site Boulder Colorado 80304 —
Novartis Investigator Site Centennial Colorado 80112 —
Novartis Investigator Site Colorado Springs Colorado 80907 —
Novartis Investigator Site Denver Colorado 80206 —
Novartis Investigative Site Glastonbury Connecticut 06033 —
Novartis Investigative Site Waterbury Connecticut 06708 —
Novartis Investigator Site Clearwater Florida 33765 —
Novartis Investigator Site Destin Florida 32541 —
Novartis Investigator Site Maitland Florida 32751 —
Novartis Investigator Site Miami Florida 33125 —
Novartis Investigator Site Miami Beach Florida 33140 —
Novartis Investigator Site Ocala Florida 34471 —
Novartis Investigator Site Pensacola Florida 32503 —
Novartis Investigator Site Pensacola Florida 32504 —
Novartis Investigator Site Pensacola Florida 32514 —
Novartis Investigator Site Port Orange Florida 32127 —
Novartis Investigator Site South Miami Florida 33143 —
Novartis Investigator Site Tamarac Florida 33321 —
Novartis Investigator Site Tampa Florida 33603 —
Novartis Investigator Site Tampa Florida 33613 —
Novartis Investigator Site Couer D'Alene Idaho 98314 —
Novartis Investigator Site Downers Grove Illinois 60515 —
Novartis Investigator Site Elk Grove Village Illinois 60007 —
Novartis Investigator Site River Forest Illinois 60305 —
Novartis Investigator Site Springfield Illinois 62781 —
Novartis Investigator Site Shawnee Kansas 66217 —
Novartis Investigator Site Crescent Springs Kentucky 41017 —
Novartis Investigator Site Lexington Kentucky 40504 —
Novartis Investigator Site Louisville Kentucky 40202 —
Novartis Investigator Site Shreveport Louisiana 71103 —
Novartis Investigative Site Waldorf Maryland 20602 —
Novartis Investigative Site Burlington Massachusetts 01803 —
Novartis Investigator Site Troy Michigan 48085 —
Novartis Investigator Site Chaska Minnesota 55318 —
Novartis Investigator Site Edina Minnesota 55435 —
Novartis Investigative Site Minneapolis Minnesota 55402 —
Novartis Investigator Site Rochester Minnesota 55905 —
Novartis Investigator Site Saint Paul Minnesota 55130 —
Novartis Investigator Site Columbia Missouri 65212 —
Novartis Investigator Site Kansas City Missouri 64128 —
Novartis Investigator Site Ozark Missouri 65721 —
Novartis Investigator Site St Louis Missouri 63110 —
Novartis Investigator Site St Louis Missouri 63141 —
Novartis Investigator Site St Louis Missouri 63317 —
Novartis Investigator Site Billings Montana 59102 —
Novartis Investigator Site Kalispell Montana 59901 —
Novartis Investigator Site Bellevue Nebraska 68005 —
Novartis Investigator Site Lincoln Nebraska 68516 —
Novartis Investigator Site Papillion Nebraska 68046 —
Novartis Investigator Site Henderson Nevada 89014 —
Novartis Investigative Site Brick New Jersey 08723 —
Novartis Investigative Site New Brunswick New Jersey 08902 —
Novartis Investigative Site Ocean City New Jersey 07712 —
Novartis Investigative Site Bayside New York 11361 —
Novartis Investigative Site Great Neck New York 11023 —
Novartis Investigative site Larchmont New York 10538 —
Novartis Investigative Site Burlington North Carolina 27215 —
Novartis Investigator Site Charlotte North Carolina 28207 —
Novartis Investigator Site Charlotte North Carolina 28277 —
Novartis Investigative Center Raleigh North Carolina 27607 —
Novartis Investigative Site Shelby North Carolina 28150 —
Novartis Investigator Site Statesville North Carolina 28625 —
Novartis Investigative Site Winston-Salem North Carolina 27103 —
Novartis Investigator Site Fargo North Dakota 58103 —
Novartis Investigator Site Grand Forks North Dakota 58201 —
Novartis Investigative Site Akron Ohio 44313 —
Novartis Investigator Site Cincinnati Ohio 45231 —
Novartis Investigator Site Cincinnati Ohio 45242 —
Novartis Investigator Site Cleveland Ohio 44109 —
Novartis Investigator Site Toledo Ohio 43608 —
Novartis Investigator Site Oklahoma City Oklahoma 73104 —
Novartis Investigator Site Eugene Oregon 97401 —
Novartis Investigative Site Allentown Pennsylvania 18103 —
Novartis Investigative Site Beaver Pennsylvania 15009 —
Novartis Investigative Site Erie Pennsylvania 16506 —
Novartis Investigative site Philadelphia Pennsylvania 19104 —
Novartis Investigative Site Philadelphia Pennsylvania 19140 —
Novartis Investigative Site Phoenixville Pennsylvania 19460 —
Novartis Investigative Site Pawtucket Rhode Island 02860 —
Novartis Investigative Site Providence Rhode Island 02903 —
Novartis Investigator Site Charleston South Carolina 29407 —
Novartis Investigator Site Easley South Carolina 26940 —
Novartis Investigator Site Greenville South Carolina 29615 —
Novartis Investigator Site North Charleston South Carolina 29406-7108 —
Novartis Investigator Site Spartanburg South Carolina 29303 —
Novartis Investigator Site Union South Carolina 29379 —
Novartis Investigator Site Dallas Texas 75216 —
Novartis Investigator Site Dallas Texas 75246 —
Novartis Investigator Site Fort Worth Texas 76109 —
Novartis Investigator Site Houston Texas 77030 —
Novartis Investigator Site Tyler Texas 75708 —
Novartis Investigator Site Salt Lake City Utah 84107 —
Novartis Investigative Site Abingdon Virginia 24210 —
Novartis Investigative Site Fredericks Virginia 22401 —
Novartis Investigator Site Renton Washington 98055 —
Novartis Investigator Site Spokane Washington 99204 —
Novartis Investigative Site Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00877383, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2011 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00877383 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →